Structure-based, C2 symmetric inhibitors of HIV protease.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1990-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00172A002PMID 2213822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renin inhibitors.

  1990cited by this paper
• Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.

  1990cited by this paper
• Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.

  1990cited by this paper
• Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

  1990cited by this paper
• Rational design of peptide-based HIV proteinase inhibitors.

  1990cited by this paper
• A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.

  1990cited by this paper
• Peptide substrates and inhibitors of the HIV-1 protease.

  1989cited by this paper
• Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

  1989cited by this paper
• Synthetic non-peptide inhibitors of HIV protease.

  1989cited by this paper
• Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

  1989cited by this paper
• Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

  1989cited by this paper
• Active human immunodeficiency virus protease is required for viral infectivity.

  1988cited by this paper
• Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.

  1988cited by this paper
• Correlation of serum HIV antigen and antibody with clinical status in HIV‐I infected patients

  1987cited by this paper
• Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.

  1987cited by this paper
• A structural model for the retroviral proteases

  1987cited by this paper
• HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

  1986cited by this paper
• Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.

  1980cited by this paper

• Ritonavir’s Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications

  2024cites this paper
• Expanding the Chemical Diversity of Grisechelins via Heterologous Expression.

  2024cites this paper
• Into the Fray! A Beginner's Guide to Medicinal Chemistry

  2021cites this paper
• Concerted hydrolysis mechanism of HIV-1 natural substrate against subtypes B and C-SA PR: insight through molecular dynamics and hybrid QM/MM studies.

  2020cites this paper
• Exploring the concerted mechanistic pathway for HIV-1 PR—substrate revealed by umbrella sampling simulation

  2020influential citation
• Theoretical Model for HIV-1 PR That Accounts for Substrate Recognition and Preferential Cleavage of Natural Substrates.

  2019cites this paper
• Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.

  2019cites this paper
• HCV NS5A as an Antiviral Therapeutic Target: From Validation to the Discovery and Development of Ombitasvir and Pibrentasvir as Components of IFN-Sparing HCV Curative Treatments

  2019cites this paper
• Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach.

  2017cites this paper
• Dynamics of the thumb-finger regions in a GH11 xylanase Bacillus circulans : comparison between the Michaelis and covalent intermediate

  2015cites this paper
• Synthesis of Novel Chiral Diamino Alcohols and Their Application in Copper‐Catalyzed Asymmetric Allylic Oxidation of Cycloolefins.

  2014cites this paper
• Chapter 5 – Enzyme Inhibition and Inactivation

  2014cites this paper
• Development of the First AIDS Drugs: AZT and Other Dideoxynueosides

  2013cites this paper
• Computational insight into the glycosidase enzyme using bioinformatics tools and molecular dynamic simulations.

  2013cites this paper
• Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres.

  2012cites this paper
• Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.

  2011cites this paper
• Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease.

  2011cites this paper
• Palladium‐catalyzed reduction of nitroaromatic compounds to the corresponding anilines

  2010cites this paper
• Update 1 of: Beta-strand mimetics.

  2010cites this paper
• Samarium‐promoted Chemoselective Reduction of Aromatic Nitro Compounds in Ionic Liquid

  2010cites this paper
• The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS

  2010cites this paper
• HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies

  2009cites this paper
• Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.

  2008cites this paper
• Structure-Based Drug Design – The Use of Protein Structure in Drug Discovery

  2007cites this paper
• Ritonavir and Lopinavir/Ritonavir

  2007cites this paper
• Ribonucleic Acid Viruses: Antivirals for Human Immunodeficiency Virus

  2007cites this paper
• Drug Discovery: Historical Perspective, Current Status, and Outlook

  2007cites this paper
• Indium(III)-catalyzed addition of diethyl acetamidomalonate to terminal alkynes: an efficient approach to beta-branched alpha-amino acids.

  2007cites this paper
• Pediatric and adolescent HIV disease.

  2007cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• HIV Therapeutics, Biochemistry of

  2006cites this paper
• Die Dihydroxyaceton‐Einheit – ein nützlicher C3‐Baustein in der Organischen Synthese

  2005cites this paper
• Differences in Binding of Stereoisomers to Protein Active Sites

  2005cites this paper
• Cyclic Sulfamide HIV-1 Protease Inhibitors : Design, Synthesis and Modelling

  2005cites this paper
• The dihydroxyacetone unit--a versatile C(3) building block in organic synthesis.

  2005cites this paper
• Structure-Assisted Design of Drugs Towards HIV-1 and Malaria Targets Applied on Reverse Transcriptase and Protease from HIV-1 and Plasmepsin II from Plasmodium falciparum

  2004cites this paper
• BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.

  2004cites this paper
• Enzyme Inhibition and Inactivation

  2004cites this paper
• Development of Enzyme Inhibitors as Drugs

  2004cites this paper
• Beta-strand mimetics.

  2004cites this paper
• HIV protease inhibition: limited recent progress and advances in understanding current pitfalls.

  2004cites this paper
• Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.

  2004cites this paper
• Thiazole-mediated synthetic methodology.

  2004cites this paper
• Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.

  2003cites this paper
• Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.

  2003cites this paper
• A novel synthesis of 5-functionalized oxazolidin-2-ones from enantiomerically pure 2-substituted N-[(R)-(+)-alpha-methylbenzyl]aziridines.

  2003cites this paper
• Studies on the viability of cyclopropane-containing peptidomimetics and application of the vinylogous Mannich reaction to the syntheses of indolizidine natural products

  2003cites this paper
• Design and synthesis of pseudo-symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-hydrazide isostere.

  2003cites this paper
• Mechanisms of Stereoselective Binding to Functional Proteins

  2003cites this paper
• X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 protease.

  2002cites this paper
• Synthesis of a tetrabenzyl-substituted 10-membered cyclic diamide

  2002cites this paper
• De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.

  2002cites this paper
• Design and Synthesis of HIV-1 Protease Inhibitors

  2001cites this paper
• Wirkstoffdesign bei der Entwicklung substratähnlicher HIV‐Protease‐Hemmstoffe: Molecular Modelling im Kampf gegen AIDS

  2001cites this paper
• Asymmetric synthesis of alpha-branched primary amines on solid support via novel hydrazine resins.

  2001cites this paper
• Synthesis of novel, potent, diol-based HIV-1 protease inhibitors via intermolecular pinacol homocoupling of (2S)-2-benzyloxymethyl-4-phenylbutanal.

  2001cites this paper
• Quantitative Structure-Activity Relationship of some HIV-1 Protease Inhibitors: A Fujita-Ban Type Analysis

  2001cites this paper
• [Molecular modeling in the battle against AIDS. Drugs design in the development of substrate-like HIV protease inhibitors].

  2001cites this paper
• A Novel Hydrazine Linker Resin and Its Application for the Solid-Phase Synthesis of alpha-Branched Primary Amines.

  2001cites this paper
• Aspartic protease inhibitors

  2000cites this paper
• Aspartic protease inhibitors. An integrated approach for the design andsynthesis of diaminodiol-based peptidomimetics.

  2000cites this paper
• Approaches to the design of effective HIV-1 protease inhibitors.

  2000cites this paper
• MBO(N)D: A multibody method for long‐time molecular dynamics simulations

  2000cites this paper
• Dipeptides containing D-serine or D-isoserine from the same (R)-aziridine-2-imide by a simple reversal of the synthetic procedure

  1999cites this paper
• Asymmetric dihydroxylation route to a dipeptide isostere of a protease inhibitor: enantioselective synthesis of the core unit of ritonavir.

  1999cites this paper
• A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection.

  1999cites this paper
• HIV Protease as a Target for the Design of Antiviral Agents for AIDS

  1999cites this paper
• Comparative Quantitative Structureminus signActivity Relationship Studies on Anti-HIV Drugs.

  1999cites this paper
• Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.

  1999cites this paper
• Strategies for Antiviral Drug Discovery

  1998cites this paper
• Synthesis of C2-symmetric dibenzyldiamino diols by double stereoselective grignard addition to (S,S)-tartraldehyde dinitrone

  1998cites this paper
• From Cycloolefins to Linear C2 -Symmetrical 1,4-Diamino-2,3-diol Building Blocks-Peptide Mimetics, Biocatalysis, and Pinacol Coupling of α-Amino Aldehydes.

  1998cites this paper
• Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy.

  1998cites this paper
• Review Strategies for antiviral drug discovery

  1998cites this paper
• Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2-hydroxy-propane derivatives.

  1998cites this paper
• Synthesis of dibenzyl iminodiacetic derivatives as potential inhibitors of HIV-1 aspartyl protease

  1998cites this paper
• Von Cycloolefinen zu linearen C2‐symmetrischen 1,4‐Diamino‐2,3‐diol‐Bausteinen – Peptidmimetica, Biokatalyse und Pinakol‐Kupplung von α‐Aminoaldehyden

  1998cites this paper
• A facile reduction of aromatic nitro compounds to aromatic amines by samarium and iodine

  1998cites this paper
• STEREOCONTROLLED SYNTHESIS OF PSEUDO C2-SYMMETRIC 1,3-DIAMINO-2-PROPANOL CORE UNITS OF HIV PROTEASE INHIBITORS

  1997cites this paper
• Structure of HOE/BAY 793 complexed to human immunodeficiency virus (HIV-1) protease in two different crystal forms--structure/function relationship and influence of crystal packing.

  1997cites this paper
• Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects

  1997cites this paper
• Anti-Human Immunodeficiency Virus Activity, Bioavailability and Drug Resistance Profile of the Novel Proteinase Inhibitor MDL 74,695

  1997cites this paper
• Clinically effective HIV-1 protease inhibitors

  1997cites this paper
• Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs

  1997influential citation
• Contributions of protein structure-based drug design to cancer chemotherapy.

  1997cites this paper
• Antiviral Activity of DG-35-VIII, a Potent Inhibitor of the Protease of Human Immunodeficiency Virus

  1997cites this paper
• Generation of homochiral aziridinium ion intermediates derived from2,3-epoxy amines: regiospecific nucleophilic trapping with nitrogennucleophiles. Application in the synthesis of novelmorpholinosphingolipid analogues with potential glucosylceramidesynthase inhibitory activity

  1997cites this paper
• Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors.

  1997cites this paper
• Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure.

  1997cites this paper
• Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease

  1997cites this paper
• Human Immunodeficiency Virus Protease Inhibitors

  1997cites this paper
• Synthesis of novel C2-symmetric and pseudo C2-symmetric based diols, epoxides and dideoxy derivatives of HIV protease inhibitors

  1997cites this paper
• The role of computer-aided and structure-based design techniques in the discovery and optimization of cyclic urea inhibitors of hiv protease

  1997cites this paper
• Synthesis of primary amines via nucleophilic addition of organometallic reagents to aldimines on solid support

  1997cites this paper
• Synthesis of new potential aminopeptidase inhibitors by Lewis acid induced rearrangement of 2,3-epoxy amines and regiospecific nucleophilic trapping of aziridinium ion intermediates with α-amino esters

  1997cites this paper
• Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases.

  1996cites this paper
• Protease inhibitors: a new weapon and a new strategy against HIV.

  1996cites this paper
• Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.

  1996cites this paper
• 7 – Modeling Drug–Receptor Interactions

  1996cites this paper
• Synergistic binding of inhibitors to the protease from HIV type 1.

  1996cites this paper